| Particulars |
| Company Name |
Aurobindo Pharma Ltd |
| Face Value |
1 |
| BSE Code |
524804 |
| Year End |
202503 |
| Full Year |
| Equity (Rs in Cr.) |
58.08 |
| B.V. Rs |
369.20 |
| Sales Rs in Cr. |
10,933.30 |
| NP Rs in Cr. |
1,741.31 |
| NP Var% |
-11.00 |
| Div% |
0.00 |
| CPS Rs |
35.10 |
| EPS Rs |
30.00 |
| Traded Value(Rs in Lakhs) |
635.65 |
| 52 Week High |
1,331.00 |
| 52 Week Low |
994.00 |
| Price BSE |
1,314.00 |
| Price NSE |
1,314.00 |
| Market Capital(Rs in Cr.) |
76,302.81 |
| P/C Ratio |
37.40 |
| P/E Ratio |
43.80 |
| Price Vs.BV |
3.56 |
| Latest Quarter |
| Year End |
202512 |
| Sales Rs in Cr. |
2,726.38 |
| NP Rs in Cr. |
594.94 |
| NP Var % |
26.00 |
| Trailing Twelve Months |
| Year End |
202512 |
| Sales |
10,713.37 |
| OPM |
23.28 |
| NP |
2,069.02 |
| NP Var% |
11.80 |
| EPS |
36.91 |
| PE |
35.59 |
|